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Abstract
Bone loss is caused by the dysregulated activity of osteoclasts which degrade the extracellular
bone matrix. The tyrosine kinase Pyk2 is highly expressed in osteoclasts, and mice lacking Pyk2
exhibit an increase in bone mass, in part due to impairment of osteoclast function. Pyk2 is
activated by phosphorylation at Y402 following integrin activation, but the mechanisms leading to
Pyk2 dephosphorylation are poorly understood. In the current study, we examined the mechanism
of action of the dynamin GTPase on Pyk2 dephosphorylation. Our studies reveal a novel
mechanism for the interaction of Pyk2 with dynamin, which involves the binding of Pyk2’s FERM
domain with dynamin’s plextrin homology domain. In addition, we demonstrate that the
dephosphorylation of Pyk2 requires dynamin’s GTPase activity and is mediated by the tyrosine
phosphatase PTP-PEST. The dephosphorylation of Pyk2 by dynamin and PTP-PEST may be
critical for terminating outside-in integrin signaling, and for stabilizing cytoskeletal reorganization
during osteoclast bone resorption.
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1. Introduction
Osteoclasts (OCs) are bone-resorbing multinuclear cells derived from hematopoietic stem
cells that play a key role in bone remodeling (Canalis, 2005, Suda et al., 1997). OCs are
activated upon adhesion to the bone surface. This results in cytoskeletal rearrangement and
formation of the podosome belt/sealing zone which contains highly dynamic actin-rich
structures known as podosomes. The podosome belt is important for cell attachment and for
circumscribing the ruffled border membrane through which resorption occurs (Vaananen
and Horton, 1995, Novack and Faccio, 2009). However, the proteins and cellular
mechanisms that regulate podosome belt formation are not well understood.
Proline-rich tyrosine kinase 2 (Pyk2) and the focal adhesion kinase (FAK) are known to play
an essential role in cell adhesion (Parsons, 2003, Richardson and Parsons, 1995). Pyk2 is a
multi-domain protein containing an N-terminal FERM domain, a central catalytic core,
several proline rich domains (PRD) and a C-terminal focal adhesion targeting (FAT) domain
(Avraham et al., 2000, Han et al., 2009, Gil-Henn et al., 2007) (Fig. 1A). The FERM domain
is found in a number of proteins and is involved in localizing proteins to the plasma
membrane and binding to PIP2 (Chishti et al., 1998, Hamada et al., 2000). In response to
integrin engagement and in the presence of intracellular calcium [Ca2+]i, Pyk2 is
autophosphorylated at tyrosine residue Y402, which is essential for its activity and for
downstream signaling (Mitra et al., 2005, Dikic et al., 1996, Avraham et al., 2000). In OCs,
Pyk2 is localized to the podosome belt and deletion of Pyk2 leads to an impairment of OC
function, which in part contributes to the osteopetrotic phenotype observed in Pyk2-deficient
mice (Gil-Henn et al., 2007, Buckbinder et al., 2007).
Dynamin is a GTP-hydrolyzing enzyme (GTPase) that is involved in membrane fission
during clathrin-mediated endocytosis (Schmid et al., 1998). Dynamin has four major
domains: an N-terminal GTPase domain, a pleckstrin homology domain (PH) which
mediates interaction with membranes lipids, a GTPase effector domain (GED) which is
essential for self-assembly and for stimulated GTPase activity, and a C-terminal proline rich
domain (PRD) which contains several SH3-binding sites (Hinshaw, 2000, Ahn et al., 2002,
Heymann and Hinshaw, 2009). Similar to Pyk2, we found that dynamin localizes to the
podosome belt in OCs and we reported that dynamin regulates actin remodeling in the
podosomes of OCs (Bruzzaniti et al., 2005, Ochoa et al., 2000). We previously reported that
dynamin decreases Pyk2 phosphorylation at Y402 and reduces Src binding to Pyk2
(Bruzzaniti et al., 2009). However, the mechanism of action of dynamin on Pyk2, whether
dynamin promotes the dephosphorylation of Pyk2 Y402, or alternatively prevents Pyk2
from being phosphorylated, and the downstream effects on signaling in OCs is unknown. In
the current study we demonstrate that Pyk2 associates with dynamin via a novel interaction
involving the Pyk2-FERM and dynamin-PH domains. Furthermore, our findings suggest
that dynamin acts in a GTPase-dependent manner to regulate Pyk2 dephosphorylation via
the tyrosine phosphatase PTP-PEST. The dephosphorylation of Pyk2 is likely to terminate
Pyk2 downstream signaling, leading to the reorganization of the actin podosome belt and to
a decrease in OC bone resorbing activity.
2. Materials and methods
2.1. Plasmids
Full-length Pyk2 was generated as previously described (Lev et al., 1995, Dikic et al., 1996,
Sieg et al., 1998). Pyk2ΔFAT (residues 1-861), Pyk2ΔFERM (residues 367-1009), PRD
(residues 690-861), FAT (residues 862-1009) were excised from Pyk2 (wt) and inserted into
mammalian vector pEF6/V5-His with in-frame fusion of the V5 epitope at the C-terminal.
All Pyk2 cDNA fragments were verified by sequencing and restriction mapping. Dynamin
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DNA fragments (GTPase-GST, PH-GST, GED-GST, and PRD-GST) were kindly provided
by Dr. V. Shah (Minneapolis, MN) and Dr. C.S. Lee (Seoul, S. Korea). A construct of rat
dynamin-2 (splice variant aa) (Cao et al., 1998) and the dynamin-2 mutant dynK44A
inserted into the pEGFP-N1 vector were generated as previously described (Damke et al.,
1994, Altschuler et al., 1998). DynΔPRD was provided by P. De Camilli (Yale University,
New Haven, CT). PTP-PEST (wt) and PTP-PEST (R237M) mutant were kindly provided by
A. Veillette (Laboratory of Molecular Oncology, Montréal, Québec).
2.2. Preparation of cells
OC precursors were isolated from the bone marrow of 6-8 week old C57Bl/6 mice and
differentiated in vitro for 6-8 days with macrophage colony-stimulating factor (M-CSF, 20
ng/ml) and receptor activator of NFκB ligand (RANKL, 80 ng/ml) (Kalliolias et al., 2010).
293VnR cells (HEK293; human embryonic kidney cells stably overexpressing the avβ3 or
vitronectin receptor) were previously described and validated (Bruzzaniti et al., 2005).
293VnR cells were transfected using FuGENE 6 according to manufacturer’s protocols
(Roche Diagnostics, Indianapolis, IN). For most experiments, a ratio of 2 μg Pyk2 to 1 μg
of dynamin was used for these experiments, unless otherwise indicated.
2.3. Immunoprecipitation and GST pull-down assays
OC cultures or transfected 293VnR cells were serum starved for 24 h, washed with
phosphate buffered saline (PBS) and lysed in modified RIPA (mRIPA) buffer (50 mM Tris-
HCl, pH 7.4), 150 mM NaCl, 5 mM EDTA, 1% NP40, 1% sodium deoxycholate, 0.1%
SDS, 50 mM NaF, 1% aprotinin and 0.1mM Na3VO4). Immunoprecipitations (IPs) and
Western blotting were performed as previously published (Bruzzaniti et al., 2005). Protein
blots were quantified by densitometry analysis using ImageJ software (http://
rsb.info.nih.gov/ij/).
GST pull-down assays using anti-GST antibodies were performed as reported (Izumi et al.,
2009, Bachand et al., 2002). Briefly, dynamin fragments (GTPase-GST, PH-GST, GED-
GST, and PRD-GST) were expressed in bacterial cells induced with IPTG (1mM) for 4 hrs.
Bacterial pellets were resuspended with B-PER Protein Extraction Reagents (Pierce,
Rockford, IL). Lysates were sonicated, cleared by centrifugation and resuspended in
refolding buffer containing 20 mM HEPES-KOH pH 7.5, 150 mM KCl, 1 mM EDTA, 1mM
EGTA, 0.5 mM DTT (Leonard et al., 2005). Anti-GST antibody was added to the refolding
mixture and incubated for 2 hrs at 4°C. Protein G agarose beads were added and rocked
gently for 1hr at 4°C. Cleared lysates from Pyk2-transfected 293VnR cells were added to the
dynamin-GST-beads and incubated for 2 hrs at 4°C. Washing and centrifugation were
repeated 4 times before proceeding to SDS-PAGE and Western blotting.
3. Results
3.1. Characterization of the effects of dynamin mutants on Pyk2 phosphorylation
Specific point mutations within dynamin are reported to regulate dynamin’s GTPase activity
(Fig. 1C). Therefore, to begin to investigate the mechanism by which dynamin regulates
Pyk2 and to determine the role of dynamin’s GTPase activity on Pyk2 Y402
phosphorylation, we used several known dynamin mutants (K44A, S61D, T141A and
I684K) which have differential effects on dynamin’s catalytic activity (Fig 1C). Pyk2 was
co-expressed in the presence or absence of the dynamin mutants and proteins were
immunoprecipitated (IP’d) and subject to SDS-PAGE and Western blotting (Fig. 2A-C).
Densitometric analyses were then performed to determine the ability of the dynamin mutants
to form a complex with Pyk2, and to regulate Pyk2 Y402 phosphorylation (Fig. 2A-C). We
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found that Pyk2 co-immunoprecipitated (co-IP’d) with wild-type dynamin (dynWT) as well
as all mutants (Fig. 2A). However, dynK44A, dynS61D and dynT141A associated with
Pyk2 to a greater extent than dynWT (up to 250-350% increase), whereas the association of
Pyk2 with dynI684K was similar to dynWT.
We next determined if Pyk2 phosphorylation was differentially affected by the various
dynamin mutants (Fig. 2B). We found that Pyk2 phosphorylation was almost completely
abolished in the presence of dynWT, whereas dynK44A and dynS61D only showed a
35-40% decrease. This finding was surprising given that these mutants associated with Pyk2
to a greater extent than dynWT (Fig. 2A). In contrast, Pyk2 phosphorylation was
significantly decreased (90% decrease) by dynT141A (Fig. 2B), which was found to
strongly associate with Pyk2 (Fig. 2A). Since dynK44A and dynS61D are catalytically-
inactive, these findings suggest that Pyk2 dephosphorylation requires dynamin’s catalytic
activity. Of further interest, the assembly-defective mutant dynI684K decreased Pyk2
phosphorylation (90% decrease) to a greater extent than dynWT, even though its catalytic
activity is reported to be reduced (Fig. 1C). To further examine if dynamin’s GTPase
activity was important for its ability to decrease Pyk2 phosphorylation, we performed
similar experiments in the presence of the synthetic dynamin GTPase inhibitor, dynasore
(Kirchhausen et al., 2008, Nankoe and Sever, 2006). 293VnR cells were transfected with
Pyk2 and either dynWT or dynI684K and treated with dynasore for 1 hr. As shown in Fig.
2C, densitometric analyses revealed increased Pyk2 phosphorylation in the presence of
dynasore. In addition, dynasore increased Pyk2 phosphorylation in cells expressing Pyk2
and dynWT or dynI684K. This finding was consistent with the increase in Pyk2
phosphorylation we observed in cells co-expressing the GTPase-inactive mutants,
dynK444A and dynS61D, compared with dynWT (Fig. 2B). Therefore, our findings indicate
that the catalytic activity of dynamin, as well as conformational changes in dynamin, is
important for regulating dynamin’s effects on Pyk2 phosphorylation.
3.2. Pyk2-dynamin association involves the Pyk2 FERM and the dynamin PH domains
Dynamin and Pyk2 lack obvious complementary motifs through which the direct binding of
these proteins may occur. Therefore, to identify the molecular domains involved in the
association of dynamin and Pyk2 complexes, we examined the interaction of several
dynamin and Pyk2 truncated proteins. First, we compared whether the PRD domains in
dynamin or Pyk2 are critical for their mutual association. We found by co-IP that Pyk2
associated with both dynWT and dynΔPRD (lacking the PRD), although its association with
dynΔPRD was significantly less than that observed with dynWT (Fig. 3A). This suggested
that non-canonical molecular domains were involved in mediating protein complexes. To
further elucidate the intramolecular domains involved, we performed GST pull-down assays
using truncated dynamin domains. As shown in Fig. 3B, Pyk2 was not detected in pull-down
assays using the isolated GTPase or GED domains. However, Pyk2 associated strongly with
the dynamin PH domain, while the PRD exhibited reduced association. We next performed
GST pull-down experiments to examine which domain of Pyk2 participated in the dynamin-
Pyk2 complexes. Our findings revealed that Pyk2ΔFAT and the isolated FERM domain of
Pyk2 both associated with the PH domain of dynamin (Fig. 3C). In addition, we found that
full-length dynamin strongly co-IP’d with the isolated FERM domain, but not with Pyk2
lacking the FERM domain (Pyk2ΔFERM) (Fig. 3D). Together, these findings indicate that
the Pyk2 FERM and dynamin PH domains are likely to be the major domains involved in
the association of these proteins.
3.3. PTP-PEST regulates the dynamin-induced decrease in Pyk2 phosphorylation
The decrease in Pyk2 phosphorylation that we observed could be the result of a block in the
initial autophosphorylation of Pyk2 or the result of Pyk2 dephosphorylation by tyrosine
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phosphatases. To examine the mechanism of Pyk2 dephosphorylation, Pyk2 was expressed
in 293VnR cells in the presence or absence of dynamin. Cells were then treated with a broad
spectrum tyrosine phosphatase inhibitor, phenyl arsine oxide (PAO) using increasing
inhibitor concentrations and incubation times (Fig. 4A and 4B). Protein complexes were
analyzed by Western blotting to detect Pyk2 Y402 phosphorylation, followed by
densitometry. Comparable levels of Pyk2 were IP’d as indicated by the control blots
(IP:Pyk2, B:Pyk2). These studies revealed that Pyk2 phosphorylation was increased in the
presence of PAO in a dose and time-dependent manner (Fig. 4A and 4B, respectively).
Although Pyk2 phosphorylation was dramatically decreased by dynWT (Fig 4A and 4B,
compare Pyk2 alone and Pyk2+dyn), PAO significantly reversed the inhibitory effect of
dynamin on Pyk2 phosphorylation in a concentration and time-dependent manner. These
findings therefore suggested that a specific tyrosine phosphatase was involved in the
dynamin-induced dephosphorylation of Pyk2. We next examined whether dynamin’s
assembly was important in the ability of PAO to restore Pyk2 phosphorylation. We therefore
expressed Pyk2 in the presence of either dynWT or dynI684K, and treated cells with the
optimal dose of PAO (15 μM for 60 min) (see Fig 4A and 4B). As shown in Fig. 4C,
dynWT and dynI684K both induced Pyk2 dephosphorylation, which was partially reversed
by PAO. Interestingly, the effect of PAO on Pyk2 dephosphorylation appeared greater for
dynI684K than dynWT, again suggesting that the GTPase activity of dynamin as well as its
conformation may be important for Pyk2 dephosphorylation, since dynI684K is defective in
its ability to hydrolyze GTP (Fig. 1C). Finally, to determine if PAO led to the
dephosphorylation of Pyk2 while it was in complex with dynamin, we expressed Pyk2 and
in 293VnR cells and then IP’d dynamin and blotted for the presence of phosphorylated Pyk2
Y402. As shown in Fig. 4D, PAO increased the amount of phosphorylated Pyk2 that IP’d
with dynamin. Together, our data suggested that a tyrosine phosphatase was likely to be
present in the dynamin-Pyk2 complex, leading to Pyk2 dephosphorylation. However, it is
possible that some Pyk2 may be dephosphorylated prior to its association with dynamin. the
finding that dynWT still IP’d with Pyk2 in the presence of PAO (Fig. 4A and 4B, blot 2)
indicated that dephosphorylated Pyk2 remained in complex with dynamin.
The tyrosine phosphatase PTP-PEST is essential in regulating both cell spreading and
migration by inducing the dephosphorylation of several focal adhesion-associated proteins
(Shen et al., 1998, Angers-Loustau et al., 1999). It has also been reported that PTP-PEST
specifically dephosphorylates Pyk2 Y402 (Lyons et al., 2001, Sahu et al., 2007) and is
inhibited in the presence of PAO or Na3VO4. We therefore investigated the role of PTP-
PEST in the dynamin-regulated dephosphorylation of Pyk2. Dynamin and Pyk2 were
cotransfected with PTP-PEST (PEST) or an inactive R237M mutant of PTP-PEST
(R237M), which is known to act as a dominant negative mutant (Davidson and Veillette,
2001, Shen et al., 1998, Angers-Loustau et al., 1999, Turner, 2000, Lyons et al., 2001). As
shown in Fig. 5A, Pyk2 co-IP’d with active PTP-PEST and inactive PEST-R237M. Pyk2
phosphorylation was decreased in the presence of PTP-PEST, but significantly increased by
PEST-R237M. A possible explanation for this is that over-expression of inactive PEST-
R237M displaces endogenous PTP-PEST or other phosphatases from Pyk2, leading to an
overall increase in Pyk2 phosphorylation. Next, Pyk2 was co-expressed with dynamin and
either active PTP-PEST or inactive PEST-R237M. Similarly to our earlier findings, PTP-
PEST decreased Pyk2 phosphorylation while PEST-R237M significantly rescued Pyk2
Y402 phosphorylation in the presence of dynamin (Fig. 5B). We then examined whether
dynamin’s activity was required for the association of Pyk2 and PTP-PEST (Fig. 5C).
293VnR cells expressing various combinations of dynWT, Pyk2 and PTP-PEST were
treated with dynasore or vehicle (DMSO) and then subject to IP and Western blotting. As
shown in Fig. 5C, dynasore decreased the amount of Pyk2 that was in complex with PTP-
PEST (blot 1). We also found that the association of dynamin with PEST also decreased in
the presence of dynasore (blot 2), suggesting that dynamin’s GTPase activity was important
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for the protein complex to form. Next, we used the GTPase-inactive dynK44A mutant to
further examine if dynamin’s association with PTP-PEST requires its GTPase activity, or the
presence of Pyk2 (Fig. 5D). Indeed, dynamin co-IP’d with PTP-PEST in the presence or
absence of Pyk2 (293VnR cells lack endogenous Pyk2). However, we found more PTP-
PEST in complex with dynWT than dynK44A, confirming that dynamin’s GTPase activity
is important for its association with PTP-PEST. Of interest, co-expression of Pyk2 increased
the formation of both the dynamin-PTP-PEST and dynK44A-PTP-PEST complexes,
suggesting cooperative binding of these proteins. Finally, we examined if PTP-PEST
enhanced the association of dynWT or dynK44A with Pyk2 (Fig. 5D, blot 2 and 3).
Although dynK44A associated more strongly with Pyk2 than dynWT (as previously shown
in Fig. 1B), PTP-PEST enhanced the formation of Pyk2-dynamin complexes. These findings
further suggested a cooperative association, rather than competitive interaction of these
proteins. Our findings also suggest that PTP-PEST is involved in the dynamin-induced
dephosphorylation of Pyk2. Furthermore, the association of PTP-PEST to dynamin may be
regulated by the GTPase activity of dynamin.
3.4. Dynamin, Pyk2 and PTP-PEST form a complex in OCs and regulate podosome belt
formation
To further elucidate the role of PTP-PEST in the dephosphorylation Pyk2 in OCs, we
determined whether these proteins formed a complex in OCs. As shown in Fig. 6A, Pyk2
formed a protein complex with both dynamin and PTP-PEST in OCs. Similarly, PTP-PEST
formed a complex with both dynamin and Pyk2, indicating that these three molecules were
potentially part of the same molecular complex. In addition, we used microscopic analyses
to examine whether podosome belt formation, which is critical for OC function, is affected
by inhibition of phosphatase activity. First, we examined if Pyk2 colocalizes with PTP-
PEST in the OC podosome belt and whether PAO, which increased Pyk2 phosphorylation in
a time and concentration-dependent manner (Fig. 4), affected the cellular localization of
these proteins. Consistent with our co-IP studies, Pyk2 colocalized with dynamin as well as
with PTP-PEST within the podosome belt in OCs (Fig. 6B). In addition, Pyk2 colocalized
with dynamin and PTP-PEST in both untreated and PAO-treated OCs. Of interest, we found
that Pyk2, dynamin and PTP-PEST were more concentrated to the cell periphery in PAO-
treated cells compared to vehicle-treated cells. We next examined the extent to which PAO
affected podosome belt formation in OCs. OCs were treated with or without PAO and the
number of cells presenting a peripheral podosome belt were then quantified. As shown in
Fig. 6C, in PAO-treated OCs, the podosome belt appeared as a tight band localized to the
cell periphery. Furthermore, we found a two-fold increase in the number of OCs containing
a peripheral podosome belt following PAO-treatment, suggesting that inhibition of
phosphatase activity is likely to decrease OC bone resorption.
4. Discussion
OC adhesion and bone resorbing activity requires the assembly of podosomes in the sealing
zone/podosome belt which is stabilized by the microtubule network (Gil-Henn et al., 2007).
However the signaling proteins involved in the rapid assembly, organization and
disassembly of podosomes are not clearly understood. We previously reported that dynamin
regulates OC bone resorption in part by decreasing Pyk2 Y402 phosphorylation, which
decreases binding to the downstream signaling protein, Src (Bruzzaniti et al., 2009). Our
studies now demonstrate the dynamin leads to the dephosphorylation of Pyk2 via
recruitment of the tyrosine phosphatase PTP-PEST. Furthermore, we found that dynamin,
Pyk2 and PTP-PEST are part of the same molecular complex. In addition, we identified a
novel mechanism of interaction of dynamin and Pyk2 which predominantly involves the
dynamin PH domain and the Pyk2 FERM domain. Finally, we demonstrated that the
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inhibition of tyrosine phosphatases stabilizes the podosome belt at the cell periphery, which
is likely to significantly affect the bone resorbing activity of OCs.
The phosphotyrosine phosphatase inhibitors PAO and Na3VO4 are both known to inhibit
PTP-PEST and we found that PAO (Fig. 4) and Na3VO4 (data not shown) rescued Pyk2
phosphorylation in the presence of dynamin, consistent with the prediction that PTP-PEST is
involved in Pyk2 dephosphorylation. In unpublished studies, we also found that Pyk2 co-IPs
with PTP-1α, PTP-1β and SHP-2 and that the phosphatase inhibitors PTP-IV (which
inhibits SHP-2, PTP1B, PTP-ε, PTP-Meg-2, PTP-σ, PTP-β, and PTP-μ) and okadaic acid
led to an increase in Pyk2 phosphorylation. However, the rescue of Pyk2 phosphorylation
with these inhibitors was much lower than that results with PAO (data not shown).
Therefore, PTP-PEST is likely to be a major phosphatase involved in Pyk2 Y402
dephosphorylation in the presence of dynamin, although other phosphatases may also be
involved.
Our studies suggested that dynamin, Pyk2 and PTP-PEST were likely to be present as part
of the same molecular complex in OCs and when expressed in 293VnR cells. In addition,
the expression of Pyk2 enhanced dynamin’s association with PTP-PEST while over-
expression of PTP-PEST enhanced Pyk2’s association with dynamin, suggesting that the
association of these molecules within a complex was likely to be cooperative in nature.
Furthermore, we found that less dynK44A co-IP’d with PTP-PEST than dynWT, and the
expression of PTP-PEST enhanced the association of dynK44A with Pyk2 (Fig. 5D).
Consistent with this, we found that in the presence of dynasore or dynK44A, the association
of Pyk2 and PTP-PEST was increased, suggesting that dynamin’s GTPase activity regulates
the formation of a multi-protein complex. It is possible that the transition of dynamin from
GTP-bound to GDP-bound influences the binding of PTP-PEST to dynamin in the complex,
which consequently may impact Pyk2 dephosphorylation. It should be noted that dynamin
can be tyrosine phosphorylated by Src kinase (Ahn et al., 2002), but the phosphatase
involved in dynamin’s dephosphorylation has not yet been determined. Our studies reveal
that dynamin forms a complex with PTP-PEST in the presence or absence of Pyk2 (Fig.
5D), indicating that dynamin may be a substrate of PTP-PEST. Together, our findings
support the hypothesis that Pyk2 dephosphorylation in the presence of dynamin is mediated
by PTP-PEST and that dynamin leads to the dephosphorylation of Pyk2 via PTP-PEST, a
step that is likely to occur after Pyk2’s initial autophosphorylation.
The GTPase domain of dynamin contains four distinct structural domains (G1, G2, G3 and
G4) that play a major role in binding the guanine nucleotide (GTP) base as well as
phosphate/Mg+2 ions (Song et al., 2004a). Residues around G2 and G3 interact with the γ-
phosphate of bound GTP, and form the switch 1 and switch 2 regions of the GTPase and are
known to alter their conformation upon GTP binding. The critical role of the G1 and G2
domain on dynamin’s GTPase activity was previously demonstrated using the point mutants
K44A and S61D (G1 and G2, respectively) (Fig. 1B) (Song et al., 2004a). In addition, these
mutants can act as dominant negatives against dynWT in over-expression studies. In
contrast, a single point mutation in the G3 domain (T141A) increases dynamin’s catalytic
activity. The GTP effector domain (GED) is also reported to bind the GTPase domain and
act as an intramolecular GTP-activating protein (GAP), and mutations in this domain
significantly decrease dynamin’s catalytic activity (Song et al., 2004b). It was previously
reported that dynK44A and dynS61D have decreased GTPase activity, whereas dynT141A
has increased GTPase activity compared to dynWT (Damke et al., 1994, Song et al., 2004a,
Song et al., 2004b, Soulet et al., 2006, Marks et al., 2001, Lee and De Camilli, 2002)
(summarized in Fig 1C). Our findings revealed that GTP hydrolysis is important for the
ability of dynamin to promote the dephosphorylation of Pyk2 since dynK44A and dynS61D
had only a small effect on Pyk2 dephosphorylation compared to dynWT (Fig. 2). Consistent
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with this finding, we found that dynT141A, which has increased GTPase activity, associated
Pyk2 with the same affinity as dynK44A and dynS61D but reduced Pyk2 phosphorylation
by 90% compared to dynWT. Moreover, we found that Pyk2 co-IPs more strongly with
dynK44A and dynS61D than dynWT (Fig. 2A. These findings suggested that
conformational changes in dynamin’s tertiary structure may contribute to its ability to
dephosphorylated Pyk2, perhaps by decreasing the association of dynamin to PTP-PEST
(Fig. 5D). In support of this, the crystal structure of the isolated dynamin GTPase domain
demonstrates that the G2 and G3 domains, in which the S61D and T141A mutations are
located, undergo large conformational changes during their transition from GTP-bound to
GDP-bound states (Reubold et al., 2005).
In addition to a basal GTPase activity, the catalytic activity of dynamin can be stimulated by
intramolecular assembly and assembly into tetramers, a prerequisite for membrane
constriction during endocytosis (Song et al., 2004b, Chappie et al., 2010). The assembly of
dynamin is controlled by the GED domain and influences GTP binding and hydrolysis
(Damke et al., 1994, Song et al., 2004a, Song et al., 2004b, Soulet et al., 2006, Marks et al.,
2001, Lee and De Camilli, 2002). The dynI684K mutant is unable to self-assemble and also
exhibits decreased catalytic activity under basal conditions (4-fold lower than dynWT) (Fig.
1C) (Song et al., 2004b, Soulet et al., 2006). We found that dynI684K decreased Pyk2
phosphorylation to a greater extent than dynWT (Fig. 2B and 2C), further supporting the
idea that structural changes in dynamin influence the degree the binding to Pyk2 and/or
PTP-PEST.
The most commonly reported mechanism for interaction of dynamin with its downstream
binding partners involves dynamin’s PRD. Unexpectedly, our experiments demonstrated
that the major molecular domain involved in mediating the interaction of dynamin and Pyk2
was not the PRD, but the PH domain. The dynamin PH domain has been reported to be
involved in protein-lipid and protein-protein interactions (Shajahan et al., 2004) and
mutations in this domain affect the ability of lipids to stimulate dynamin GTPase activity
(Achiriloaie et al., 1999, Vallis et al., 1999). In the context of our findings, we speculate that
the association of Pyk2 with dynamin may potentially affect the ability of dynamin to be
stimulated by lipids. Of clinical interest, mutations in dynamin’s PH domain are associated
with dominant intermediate Charcot-Marie-Tooth disease (Zuchner et al., 2005). Moreover,
it has been demonstrated that alendronate, a nitrogen-containing bisphosphonate commonly
used to treat bone loss associated with osteoporosis, binds dynamin’s PH domain and
inhibits dynamin’s catalytic activity (Masaike et al., 2010). These reports further support the
idea that the interaction of the dynamin PH domain with Pyk2 potentially inhibits the
GTPase activity of dynamin.
Interestingly, our findings demonstrate that Pyk2 interacts with the dynamin PH domain via
a unique mechanism involving its N-terminal Pyk2 FERM. The interaction of FERM-
domain-containing proteins with PH-domain-containing proteins is not without precedence.
For example, the FERM-containing protein FIR can bind directly with the PH domain of the
Dbl Rho-GEFs (Kubo et al., 2002). In addition, the activation of Etk is regulated by FAK,
which is highly homologous to Pyk2, through the direct association of the Etk-PH and the
FAK-FERM domains (Chen et al., 2001). Structural studies have also shown that the FAK
FERM domain regulates FAK autophosphorylation when it binds directly to its kinase
domain, thus inhibiting access to the activation loop containing Y397 (equivalent to Y402 in
Pyk2) (Lietha et al., 2007). Moreover, Pyk2 mutants harboring amino acid changes within
the FERM domain have decreased phosphorylation compared to Pyk2, and have reduced
capacity to stimulate glioma cell migration (Loftus et al., 2009, Lipinski et al., 2006). Given
the amino acid homology between FAK and Pyk2, it is likely that the FERM domain of
Pyk2 also regulates its kinase activity by regulating access to Y402.
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Based on our findings and published data, we propose the following working model (Fig. 7).
We propose that integrin activation leads to release of the auto-inhibitory FERM domain,
enabling the activation of Pyk2. This results in the autophosphorylation and activation of
Pyk2, which promotes OC resorption. Dynamin is also activated and promotes OC
resorption. After an appropriate stimulus, PTP-PEST is recruited to dynamin and potentially
leads to the dephosphorylation of dynamin, which would in turn decrease its GTPase
activity and block OC bone resorption. PTP-PEST also cooperatively enhances dynamin PH
domain binding to Pyk2-FERM domain, which permits access to the Y402 site and enables
the dephosphorylation of Pyk2 by PTP-PEST. This would subsequently lead to the
inactivation of Pyk2 signaling cascades and to the disengagement of integrins. Consistent
with cooperative interaction of these proteins, we found that PAO treatment of OCs
increased the colocalization of Pyk2, dynamin and PTP-PEST at the cell periphery, where
podosome disassembly is likely to occur.
In conclusion, our data confirm an important role of dynamin GTPase activity in the
regulation of Pyk2 phosphorylation. Our studies further demonstrate that dynamin and PTP-
PEST control the dephosphorylation of Pyk2 which is critical for the organization of the
podosome belt and for OC bone resorbing activity. These studies also raise the possibility
that therapeutic strategies that target dynamin’s PH domain or Pyk2’s FERM domain, which
are predicted to inhibit bone resorption, may be useful for the treatment of bone loss
associated with osteoporosis or related bone diseases.
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Fig. 1.
Protein structural domains and the effect of point mutations on dynamin’s GTPase activity.
(A) Schematic representation of Pyk2 domain structure. Pyk2 contains a central catalytic
domain, flanked by non-catalytic N-terminal and C-terminal domains. The C-terminal
region has two PRDs and a FAT domain. The Y402 autophosphorylation site is indicated.
(B) Schematic representation of dynamin’s domain structure. Dynamin contains a GTPase
domain followed by a middle domain, PH, GED and PRD domain. (C) Summary of the
effect of dynamin point mutants on dynamin’s Km, catalytic activity and GTP hydrolysis.
The reported Km and Kcat values are for human dynamin 1 and are based on the Michaelis-
Menten equation (Song et al., 2004b) (n/d; not determined).
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Fig. 2.
Effect of dynamin point mutants on Pyk2 binding and phosphorylation. (A) IPs and Western
blotting of Pyk2 co-expressed with dynWT, dynK44A, dynS61D, dyn1T41A or dynI684K
in 293VnR cells. The amount of Pyk2 complexed with dynamin mutants was determined by
densitometry analysis of IP:Pyk2/B:GFP blots. Results are expressed as a percentage
relative to dynWT after normalizing for total Pyk2 in IPs (blot 2) or normalizing for the
level of dynamin mutants in TCL blots (blot 3), which gave similar results. As controls,
Pyk2 was IP’d with anti-Pyk2 and blotted for Pyk2 and total cell lysates (TCLs) were
blotted with GFP to show dynamin expression in cells. (B) IP and densitometry showing the
effects of dynamin mutants on Pyk2 phosphorylation. Pyk2 was IP’d and blotted with an
antibody to pY402Blots were analyzed by densitometry and normalized for phosphorylated
Pyk2 in control IPs (without dynamin). Results are expressed as a percentage of IP’d Pyk2,
normalized for total Pyk2 in IPs (blot 3). The expression of dynamin mutants is shown in
TCLs blotted with GFP. (C). IP and densitometry showing the effects of the synthetic
dynamin inhibitor, dynasore, on Pyk2 phosphorylation in the presence of dynWT or
dynI684K. Cells were treated with 90 μM dynasore for 1 hr. Pyk2 was IP’d and blotted with
an antibody to pY402 followed by densitometry analysis. Results are expressed as a
percentage of IP’d Pyk2. A ratio of 2 μg Pyk2 to 1 μg of dynamin was used for these
experiments.
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Fig. 3.
Association of dynamin and Pyk2 domains. (A) IP of dynWT and dynΔPRD, blotted for
Pyk2. Proteins were all expressed in 293VnR cells. (B) Bacterially-expressed dynamin
domains tagged with GST (GTPase, PH, GED, PRD) were used in GST-pull down assays to
capture V5-tagged full-length Pyk2. Proteins were detected with V5 or GST antibodies. (C)
Bacterially-expressed dynamin PH domain was used in GST-pull down assays using lysates
from 293VnR cells expressing Pyk2ΔFAT or the isolated FERM domain. (D) 293VnR cells
expressing full-length dynamin in combination with either Pyk2ΔFERM or the isolated
FERM domain were IP’d and blotted. Total cell lysates (TCLs) were blotted as indicated.
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Fig. 4.
Tyrosine phosphatases participate in the dephosphorylation of Pyk2 Y402. (A) IP and
Western blotting of 293VnR cells expressing Pyk2 in the presence or absence of dynWT and
after treatment with PAO or vehicle (dimethyl sulfoxide; DMSO). Cells were treated with
increasing concentrations of PAO 0-15 μM PAO for 30 min. As an IP control, membranes
were reblotted for Pyk2. TCL were blotted with dynWT (GFP). Bar graph represents
densitometry of pY402 expressed as a percentage of total IP’d Pyk2. Experiments were
reproduced three times. (B) 293VnR cells expressing Pyk2 and dynWT were treated with
PAO (15 μM) for 0-60 min. IP and blotting was performed as indicated. (C) 293VnR cells
expressing Pyk2 in the presence of dynWT or dynI684K were treated with 10 μM PAO for
60 min. Proteins were IP’d and blotted as indicated. (D) 293VnR cells expressing Pyk2 and
dynWT were treated with DMSO or PAO (10 μM) for 060 min. Dynamin was IP’d and the
blot was probed with an antibody to the pY402 site of Pyk2. Blots were stripped and
reblotted for dynamin (GFP). A ratio of 1 μg Pyk2 to 1 μg of dynamin was used for
experiments examining the effects of PAO.
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Fig. 5.
PTP-PEST promotes Pyk2 Y402 dephosphorylation. (A) IP and Western blotting of
293VnR cells expressing Pyk2 with either PTP-PEST (PEST) or inactive PTP-PEST-
R237M (R237M) (myc tag used). Densitometry of blots was performed and the
phosphorylation of Pyk2, expressed as a percentage of total Pyk2, is shown. (B) IP and
Western blotting of 293VnR cells expressing Pyk2 plus dynWT with either PTP-PEST or
PEST-R237M. Experiments were performed as in B. (C) IP and Western blotting of
293VnR cells expressing various combinations of dynWT, PTP-PEST or Pyk2 and treated
with 90 uM dynasore for 1 hr. Western blotting and IPs were performed as indicated. Dyn
was IP’d with a GFP antibody. (D) 293VnR cells expressing dynWT or dynK44A and either
PTP-PEST, Pyk2 or both proteins were analyzed by IP and Western blotting as indicated.
Experiments were reproduced 2-3 times.
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Fig. 6.
Dynamin, Pyk2 and PTP-PEST form a complex in OCs. (A) IP of Pyk2, dynamin and PTP-
PEST from mature OCs. TCLs were blotted as indicated. (B) Microscopic images of OCs
incubated in the presence or absence of PAO (10 μM) for 60 min. Cells were fixed and
labeled for Pyk2 (red) and dynamin (green) (upper panels). Alternatively, OCs were labeled
for Pyk2 (red) and PTP-PEST (green). Merged images show the colocalization of Pyk2 and
dynamin or Pyk2 and PTP-PEST. Scale bar indicates 10 μm. (C) Microscopic analysis of
OCs treated with PAO (10 μM) or vehicle for 60 min. OCs were stained with rhodamine
phalloidin to detect actin. Bar graph represents the percentage of OCs containing a
peripheral podosome belt relative to the total number of OCs present in cultures (>80 OCs
counted). Error bars indicate the average of 3 experiments plus SEM.
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Fig. 7.
Proposed mechanism of interaction of Pyk2, dynamin and PTP-PEST. Pyk2 is activated
following integrin engagement which involves release of the auto-inhibitory FERM and the
phosphorylation of Y402. Activated Pyk2 and downstream proteins, including dynamin,
promote OC resorption. Dynamin potentially recruits PTP-PEST in a GTPase-dependent
manner, which subsequently leads to the dephosphorylation of Pyk2 Y402, and inhibits
Pyk2 signaling cascades. The cyclic activation/inhibition of Pyk2 and dynamin potentially
regulates the attachment, resorption and detachment cycle of OCs.
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